Guggenheim keeps Universal Health Services at Buy, cuts price target to $201
TradingView reports Guggenheim kept its Buy rating on Universal Health Services and lowered its price target to $201 from $209, a 3.8% cut.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Guggenheim analysts maintained their Buy rating on Universal Health Services but reduced the price target to $201 from $209, a 3.8% decrease. TradingView reports the update, citing reference data from Benzinga.
According to the note, the new target implies a 16.7% upside from the October 28 close of $172.18.
The report also stresses that the information is not a personal recommendation and does not constitute investment advice.
why it matters
A lower target with an unchanged Buy rating is a routine adjustment to a valuation model rather than a change of stance by the analysts. The update has little effect on the broader market, but for investors in healthcare stocks it shows a more cautious view of the company's upside.
tags
instruments
sources
- Guggenheim maintains Universal Health Services at Buy, lowers price target to $201 from $209 — TradingView, 29 October 2026 at 18:26 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗